Skip to main content
. 2019 Aug 19;9(44):25861–25874. doi: 10.1039/c9ra04430b

Fig. 2. Impact of Buthionine Sulfoximine on TPPS2a-mediated Photodynamic Therapy. 4T1 breast cancer cells treated with TPPS2a, 0.6 μg ml−1, alone. (A) Cells illuminated immediately after TPPS2a washed off, with (blue line) or without (black line) BSO, 1.0 μg ml−1; (B) cells illuminated 4 h after TPPS2a washed off, with (orange broken line) or without (black broken line) BSO, 1.0 μg ml−1. Cells were illuminated up to 300 s. Cell viability was measured using the MTT assay, 24 h after illumination. Significant cell kill (P < 0.01) was shown for all groups >150 s illumination in 2B.

Fig. 2